Registration Fee: AUD$275.00
Target audience: Clinicians from all backgrounds who may potentially encounter cases, laboratory scientists and Pathologists involved in diagnostic testing, patients and anybody with an interest in knowing more about Porphyria.
Areas to be covered: General background and clinical situations where it is important to think about Porphyria. Also diagnostic testing, including genotyping, quality assurance and where assay developments are occurring. Both patient and clinician perspectives on management and challenges faced, together with insight into new treatment advances.
Expected outcomes: To understand the patho-physiology of Porphyria and know when to suspect it. To know how to exclude porphyria in an acute situation and how to proceed with diagnostic testing when a case is suspected. To have a greater understanding of all perspectives and to promote greater cooperation at the laboratory-clinician interface.
09:15 – 09:25 Introduction – Chris Florkowski/Peter Graham
09:25-09:45 Biochemistry of Porphyria- Joel Smith
09:45-10:25 Porphyria Diagnosis and Management, Clinical and laboratory Integration- Gayle Ross/ Virginia Cronin
10:25- 10:40 Q/A Session
10:40 – 11:10 Morning Tea
11:10 – 11:30 Role of Genetics in Porphyria – Jole Bojovic
11:30 – 11:50 RCPAQAP Porphyria cases for comment– Joel Smith
11:50 – 12:05 A challenging case – Chris Florkowski
12:05- 12:10 Q/A Session
12:10 – 13:00 Lunch
13:00 – 13:20 How good are our assays? Feedback from RCPAQAP – Abrar Taif
13:20 – 13:40 Where do our assays need to be? Ongoing developments – Chris Sies
13:40 – 14:00 A patient’s perspective of Porphyria – Brad Pearson
14:00- 15:00 Open Discussion
15:00 – 15:20 Afternoon tea
15:20 – 15:50 A copro-porphyria family. Challenges and progress – Cindy Towns
15:50 – 16:20 TBA
16:20 – 16:30 Open discussion & Conclusion